Volume | 57,152 |
|
|||||
News | - | ||||||
Day High | 7.2274 | Low High |
|||||
Day Low | 6.55 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Rani Therapeutics Holdings Inc | RANI | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
7.02 | 6.55 | 7.2274 | 6.99 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
361 | 57,152 | $ 6.88 | $ 393,258 | - | 1.82 - 8.75 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
10:41:54 | 11 | $ 6.56 | USD |
Rani Therapeutics Holdings Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
334.98M | 50.00M | - | 0 | -33.97M | -0.68 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Rani Therapeutics News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RANI Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 7.59 | 7.81 | 5.50 | 6.48 | 244,070 | -1.03 | -13.57% |
1 Month | 3.08 | 8.75 | 3.03 | 6.17 | 248,076 | 3.48 | 112.99% |
3 Months | 3.50 | 8.75 | 2.85 | 5.12 | 133,734 | 3.06 | 87.43% |
6 Months | 2.00 | 8.75 | 1.82 | 4.15 | 112,326 | 4.56 | 228.00% |
1 Year | 4.68 | 8.75 | 1.82 | 3.99 | 84,097 | 1.88 | 40.17% |
3 Years | 11.26 | 36.27 | 1.82 | 11.41 | 84,205 | -4.70 | -41.74% |
5 Years | 11.26 | 36.27 | 1.82 | 11.41 | 84,205 | -4.70 | -41.74% |
Rani Therapeutics Description
Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. |